Chiung Wen Wang

Title: Chiung Wen Wang: Innovator in Pharmaceutical Chemistry

Introduction

Chiung Wen Wang is a notable inventor based in Zhubei, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as dual inhibitors for various biological processes. With a total of 2 patents, his work is recognized for its potential therapeutic applications.

Latest Patents

Chiung Wen Wang's latest patents include innovative compounds that have promising applications in medicine. One of his patents focuses on peripheral alkyl and alkenyl chains extended benzene derivatives. These compounds are useful as dual autotaxin (ATX) and histone deacetylase (HDAC) inhibitors. They can be included in a pharmaceutical composition along with a pharmaceutically acceptable carrier, and are intended for the prophylaxis or treatment of various diseases and disorders. Another patent relates to NADPH oxidase inhibitors, which includes a compound of Formula I, or its various forms. This compound and its composition can be utilized to inhibit NADPH oxidase activity, showcasing the versatility and importance of his research.

Career Highlights

Chiung Wen Wang is associated with Taiwan Pharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention in the pharmaceutical industry, particularly for its innovative approach to drug development.

Collaborations

Chiung Wen Wang collaborates with esteemed colleagues such as Syaulan S Yang and Yan-Feng Jiang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Chiung Wen Wang's contributions to pharmaceutical chemistry highlight his role as a leading inventor in the field. His innovative patents and collaborative efforts continue to pave the way for advancements in medical treatments.